ARCHIMEDlife News
New cut-offs for lysosomal enzyme activities.
6. Juni 2019
We are happy to inform you that we have introduced a new diagnostic assay for the analysis of lysosomal...
Read more
TDM für Psychopharmaka: (in German)
26. Februar 2019
Quantitative Bestimmung von Psychopharmaka in Blut, Serum oder Plasma Modernste Analysetechnik mittels Klinischer Massenspektrometrie (exakt, sensitiv, schnell) Kompetente fachärztliche Auskunft...
Read more
Improving our ability to diagnose Hemoglobinopathies.
1. Oktober 2018
Results of a prospective study using High-Resolution Mass Spectrometry. The goal of our study, in cooperation with the University...
Read more
ISO 15189. We made it.
11. September 2018
ARCHIMEDlife, a new global player for laboratory diagnostics for Rare Disorders and other niche diagnostic services, receives ISO 15189...
Read more
Novel diagnostics for Rare Disorders: Fabry in females, presented at WorldSymposium
7. März 2018
The parallel measurement of lyso-GL-3 (lyso-Gb3) for Fabry disease is of high importance particularly for potential female Fabry patients,...
Read more
5 years ARCHIMEDlife – Thanks to our partners, clients and friends!
21. November 2017
The 21st of November 2017 is ARCHIMEDlife´s 5th anniversary, a proof that out of an idea you can evolve...
Read more
Become part of our readers´ community
12. November 2017
You can easily subscribe to our bi-monthly ARCHIMEDlife Newsletter and read about laboratory diagnostics, research studies, scientific publications and...
Read more
We were there: Asia-Pacific Conference on Human Genetics
6. November 2017
We took part in the 12th Asia-Pacific Conference on Human Genetics “Genomic Medicine and Clinical Practice” from 8th to...
Read more
